ClinicalTrials.Veeva

Menu

Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

Novartis logo

Novartis

Status and phase

Completed
Phase 3

Conditions

Renal Transplantation

Treatments

Drug: FTY720

Study type

Interventional

Funder types

Industry

Identifiers

NCT00239876
CFTY720A2302E1

Details and patient eligibility

About

This study will evaluate the safety and efficacy of FTY720 combined with tacrolimus and corticosteroids in patients receiving a kidney transplant

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

  • Completed the 12 month core study
  • Informed consent Exclusion Criteria
  • N/A Other protocol-defined exclusion criteria may apply.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems